Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy BioXcel Therapeutics stock (BTAI)

Buy BioXcel Therapeutics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

BioXcel Therapeutics is a biotechnology business based in the US. BioXcel Therapeutics shares (BTAI) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.78 – a decrease of 4.81% over the previous week. BioXcel Therapeutics employs 37 staff and has a trailing 12-month revenue of around $2.3 million.

Our top picks for where to buy BioXcel Therapeutics stock

Top pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you open and fund a new account within 30 days
  • Access to a financial planner
Customer must fund their Active Invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $1,000 is 0.028%. See full terms and conditions.

Top pick for best mobile experience

Go to site
  • Trade $0 commission stocks, ETFs, futures and options with as little as $1
  • After-hours trading available
  • Earn 4% interest on uninvested cash with Gold
  • 24/7 customer support

Top pick for advanced trading tools

Go to site
  • Trade stocks, options, futures, currencies, crypto, precious metals and more
  • Mobile, browser and desktop trading platforms
  • Earn 3.83% APY on your uninvested cash

How to buy BioXcel Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – BTAI. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy BioXcel Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Product Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Offer
SoFi Wealth Management logo
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.01%
Get up to $1,000 in stock when you open and fund a new account. T&C apply.
Trade stocks, ETFs, and options with zero commissions, invest in IPOs or automate your portfolio, with exclusive perks available through SoFi Plus.
Robinhood logo
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures
$0
$0
4%
Get a free stock when you successfully sign up and link your bank account.
Trade stocks, options, crypto and more, with advanced trading tools, fractional shares and exclusive perks for Gold members.
Interactive Brokers logo
Finder score
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex, Treasury Bills, Precious metals
$0
$0
3.83% Lite
4.83% Pro
Trade a wide range of assets, with global market access and pro-grade trading tools.
OPTO logo
Finder score
Stocks, ETFs
$0
$0
4%
Earn up to $300 when you deposit between $2,000–$25,000+.
Copy top-performing portfolios or build your own stock index on Opto's AI-driven thematic investing platform, and get 4% APY on your cash.
JPMorgan logo
Finder score
Mutual funds, ETFs
$0
$25,000
N/A
Get ongoing access to an advisory team with personalized financial planning and expert-built portfolios. Provider terms & conditions apply
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

BioXcel Therapeutics stock price (NASDAQ: BTAI)

Use our graph to track the performance of BTAI stocks over time.

BioXcel Therapeutics shares at a glance

Information last updated 2025-05-02.
Latest market close$1.78
52-week range$1.29 - $42.08
50-day moving average $2.11
200-day moving average $7.39
Wall St. target price$36.25
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-23.51

Is it a good time to buy BioXcel Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BioXcel Therapeutics price performance over time

Historical closes compared with the close of $1.78 from 2025-05-02

1 week (2025-04-28) -9.18%
1 month (2025-04-04) 9.20%
3 months (2025-02-05) 495.52%
6 months (2024-11-05) 163.00%
1 year (2024-05-03) -30.74%
2 years (2023-05-05) -99.52%
3 years (2022-05-05) 219.36
5 years (2020-05-05) 614.88

BioXcel Therapeutics financials

Revenue TTM $2.3 million
Gross profit TTM $123,000
Return on assets TTM -72.3%
Return on equity TTM -1766.94%
Profit margin 0%
Book value $-30.01
Market Capitalization $9.7 million

TTM: trailing 12 months

BioXcel Therapeutics share dividends

We're not expecting BioXcel Therapeutics to pay a dividend over the next 12 months.

Have BioXcel Therapeutics's shares ever split?

BioXcel Therapeutics's shares were split on a 1:16 basis on 9 February 2025 . So if you had owned 16 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BioXcel Therapeutics shares – just the quantity. However, indirectly, the new 1500% higher share price could have impacted the market appetite for BioXcel Therapeutics shares which in turn could have impacted BioXcel Therapeutics's share price.

BioXcel Therapeutics share price volatility

Over the last 12 months, BioXcel Therapeutics's shares have ranged in value from as little as $1.29 up to $42.08. A popular way to gauge a stock's volatility is its "beta".

BTAI.US volatility(beta: 0.64)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioXcel Therapeutics's is 0.642. This would suggest that BioXcel Therapeutics's shares are less volatile than average (for this exchange).

BioXcel Therapeutics overview

BioXcel Therapeutics, Inc. , together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company develops its neuroscience candidate, BXCL501, which is an investigational, proprietary, orally dissolving film formulation of dexmedetomidine in development for the treatment of agitation associated with psychiatric and neurological disorders; and its immune-oncology candidate, BXCL 701, which is an investigational oral innate immune activator for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors. It also develops IGALMI, a sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults; BXCL502 for the treatment of stress-related neuropsychiatric symptoms in dementia and other stress-related disorders; BXCL503, a drug candidate to target apathy in dementia; and BXCL504, which has the potential to address apathy and aggression in dementia. BioXcel Therapeutics, Inc. was incorporated in 2017 and is headquartered in New Haven, Connecticut. .

Frequently asked questions

null
What percentage of BioXcel Therapeutics is owned by insiders or institutions?
Currently 9.503% of BioXcel Therapeutics shares are held by insiders and 2.693% by institutions.
How many people work for BioXcel Therapeutics?
Latest data suggests 37 work at BioXcel Therapeutics.
When does the fiscal year end for BioXcel Therapeutics?
BioXcel Therapeutics's fiscal year ends in December.
Where is BioXcel Therapeutics based?
BioXcel Therapeutics's address is: 555 Long Wharf Drive, New Haven, CT, United States, 06511
What is BioXcel Therapeutics's ISIN number?
BioXcel Therapeutics's international securities identification number is: US09075P1057
What is BioXcel Therapeutics's CUSIP number?
BioXcel Therapeutics's Committee on Uniform Securities Identification Procedures number is: 09075P105

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

More guides on Finder

Go to site